Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease risk » increased risk (Expand Search), increases risk (Expand Search), disease risk (Expand Search)
Showing 121 - 140 results of 14,605 for search '(( significant decrease risk ) OR ( significant burden decrease ))', query time: 0.58s Refine Results
  1. 121
    Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells.

    Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells. by Courtney A. Swain (15170264)

    Published 2025
    Save to List
    Saved in:
  2. 122
    Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes.

    Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes. by Thomas G. Scott (4092892)

    Published 2024
    Save to List
    Saved in:
  3. 123
    Epilepsy, including probable nodding syndrome (pNS), and pNS prevalence per study county in high- and low-risk sites in South Sudan.

    Epilepsy, including probable nodding syndrome (pNS), and pNS prevalence per study county in high- and low-risk sites in South Sudan. by Luís-Jorge Amaral (16406704)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 124
    Exercise is associated with a decrease in BMI.

    Exercise is associated with a decrease in BMI. by Stephanie Y. Yang (8384520)

    Published 2022
    Save to List
    Saved in:
  5. 125
    Groupings of statistically significantly associated proteins by their biological processes.

    Groupings of statistically significantly associated proteins by their biological processes. by Alish B. Palmos (5857379)

    Published 2022
    Save to List
    Saved in:
  6. 126
    Pharmacological inhibition of EGFR decreases early fungal burden and reduces the inflammatory response.

    Pharmacological inhibition of EGFR decreases early fungal burden and reduces the inflammatory response. by Marc Swidergall (185453)

    Published 2021
    Save to List
    Saved in:
  7. 127
    FFD – main effect, original fibrosis burden.

    FFD – main effect, original fibrosis burden. by Åshild Telle (22794721)

    Published 2025
    Save to List
    Saved in:
  8. 128
    Nineteen SNPs with significant association (<i>P < </i>5 × 10<sup>−8</sup>) with risk on minJSW decrease in knee OA.

    Nineteen SNPs with significant association (<i>P < </i>5 × 10<sup>−8</sup>) with risk on minJSW decrease in knee OA. by Mieke L. M. Bentvelzen (21594442)

    Published 2025
    “…<p>Nineteen SNPs with significant association (<i>P < </i>5 × 10<sup>−8</sup>) with risk on minJSW decrease in knee OA.…”
    Save to List
    Saved in:
  9. 129
    Study population and coverage for the prevalence survey.

    Study population and coverage for the prevalence survey. by Chandra Kumar Dolla (5278010)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  10. 130
    Study population and its coverage.

    Study population and its coverage. by Chandra Kumar Dolla (5278010)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 131
    Table_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx

    Table_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.…”
    Save to List
    Saved in:
  12. 132
    Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx

    Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.…”
    Save to List
    Saved in:
  13. 133
    Image_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif

    Image_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif by Xiao-yang Gong (13103400)

    Published 2022
    “…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.…”
    Save to List
    Saved in:
  14. 134
    Table_4_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx

    Table_4_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.…”
    Save to List
    Saved in:
  15. 135
    Table_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx

    Table_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.…”
    Save to List
    Saved in:
  16. 136
    Image_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif

    Image_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif by Xiao-yang Gong (13103400)

    Published 2022
    “…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.…”
    Save to List
    Saved in:
  17. 137
    Table_3_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx

    Table_3_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…Background<p>Patients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.…”
    Save to List
    Saved in:
  18. 138
    Age-standardised rates (per 100,000 population) of rheumatoid arthritis burden attributable to smoking in 1990 and 2021, and trends from 1990 to 2021, by GBD Super-Region.

    Age-standardised rates (per 100,000 population) of rheumatoid arthritis burden attributable to smoking in 1990 and 2021, and trends from 1990 to 2021, by GBD Super-Region. by Kaibin Lin (9911049)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 139
    Capabilities expansion scenarios considered. <i><i>g</i></i><sub>GDP</sub> and <i><i>g</i></i><sub>fHE</sub> refer to the growth rate of annual GDP (in constant 2015 US$) and growth rate of fraction of GDP allocated to health (<i><i>f</i></i><sub>HE</sub>) assumed, leading to a yearly expenditure growth per scenario of [(1 + <i><i>g</i></i><sub>GDP</sub>) × (1 + <i><i>g</i></i><sub>fHE</sub>) − 1]. The normalised health expenditure (NHE) associated with each scenario (defined in

    Capabilities expansion scenarios considered. <i><i>g</i></i><sub>GDP</sub> and <i><i>g</i></i><sub>fHE</sub> refer to the growth rate of annual GDP (in constant 2015 US$) and growt... by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 140
    Impact on different areas of health.

    Impact on different areas of health. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: